The locomotor effects of quinpirole in rats depend on age and gender

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 4, 1999, Pages 821-826

  Frantz, K J ^a   Van Hartesveldt, C ^a  

^a University of Florida ^*  (United States)

Author keywords

Dopamine; Gender; Glutamate; Novelty; Nucleus accumbens; Sex differences

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; QUINPIROLE;

AGE; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FEMALE; LOCOMOTION; MALE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; DOPAMINE; DOPAMINE AGONISTS; FEMALE; GLUTAMIC ACID; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS;

ANIMALIA;

EID: 0032715488     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00162-8     Document Type: Article

References (49)

1. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients; Final rule. Fed. Reg. 63:66631-66672; 1998.
2. Andersen S.L., Rutstein M., Benzo J.M., Hostetter J.C., Teicher M.H. Sex differences in dopamine receptor overproduction and elimination. Neuroreport. 8:1997;1495-1498.
3. Andrews W.W., Mizejewski G.J., Ojeda S.R. Development of estradiol-positive feedback on luteinizing hormone release in the female rat. A quantitative study Endocrinology. 109:1981;1404-1413.
4. Archer J. Rodent sex differences in emotional and related behavior. Behav. Neurobiol. 14:1975;451-479.
5. Bauer R.H., Duncan D.L. Differential effects of d-amphetamine in mature and immature rats. Physiol. Psychol. 3:1975;312-316.
6. Bolanos C.A., Garmsen G.M., Clair M.A., McDougall S.A. Effects of the kappa-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat. Eur. J. Pharmacol. 317:1996;1-8.
7. Bolanos C.A., Glatt S.J., Jackson D. Subsensitivity to dopaminergic drugs in periadolescent rats. A behavioral and neurochemical analysis Brain Res. Dev. Brain Res. 111:1998;25-33.
8. Bronstein P.M. Open-field behavior of the rat as a function of age. Cross-sectional and longitudinal investigations J. Comp. Physiol. Psychol. 80:1979;335-341.
9. Campbell B.A., Lytle L.D., Fibiger H.C. Ontogeny of adrenergic arousal and cholinergic inhibitory mechanisms in the rat. Science. 166:1969;635-637.
10. Campbell B.A., Teghtsoonian R., Williams R.A. Activity, weight loss, and survival time of food-deprived rats as a function of age. J. Comp. Physiol. Psychol. 54:1961;216-219.
11. Campochiaro P., Coyle J.T. Ontogenic development of kainate neurotoxicity. Correlates with glutamatergic innervation Proc. Natl. Acad. Sci. USA. 75:1978;2025-2029.
12. Carlsson A., Hansson L.O., Waters N., Carlsson M.L. Neurotransmitter aberrations in schizophrenia. New perspectives and therapeutic implications Life Sci. 61:1997;75-94.
13. Carrey N., Kutcher S. Developmental pharmacodynamics. Implications for child and adolescent psychopharmacology J. Psychiatr. Neurosci. 23:1998;274-276.
14. Cassidy L.J., Jellinek M.S. Approaches to recognition and management of childhood psychiatric disorders in pediatric primary care. Pediatr. Clin. North Am. 45:1998;1037-1052.
15. Csernansky J.G., Bardgett M.E. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia. Schizophr. Bull. 24:1998;231-248.
16. Eilam D., Szechtman H. Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur. J. Pharmacol. 161:1989;151-157.
17. Estroff T.W., Schwartz R.H., Hoffmann N.G. Adolescent cocaine abuse. Addictive potential, behavioral and psychiatric effects. Clin. Pediatr. 28:1989;550-555.
18. Fombonne E. Increased rates of psychosocial disorders in youth. Eur. Arch. Psychiatr. Clin. Neurosci. 248:1998;14-21. [see comments].
19. Frantz K., Babcock D., Van Hartesveldt C. The locomotor effects of a putative dopamine D3 receptor agonist in developing rats. Eur. J. Pharmacol. 302:1996;1-6.
20. Greenamyre T., Penny J.B., Young A.B., Hudson C., Silberstein F.S., Johnston M.V. Evidence for transient perinatal glutamatergic innervation of globus pallidus. J. Neurosci. 7:1987;1022-1030.
21. Insel T.R., Miller L.P., Gelhard R.E. The ontogeny of excitatory amino acid receptors in rat forebrain - I. N-methyl-D-aspartate and quisqualate receptors. Neuroscience. 35:1990;31-43.
22. Kalivas P.W., Churchill L., Klitenick M. The circuitry mediating the translation of motivational stimuli into adaptive motor responses. Barnes C.D., Kalivas P.W. Limbic motor circuits and neuropsychiatry. 1993;237-287 CRC Press, Boca Raton, FL.
23. Koob G.F. Drug abuse and alcoholism. Overview. Adv. Pharmacol. 42:1998;969-977.
24. Lanier L.P., Isaacson R.L. Early developmental changes in the locomotor response to amphetamine and their relation to hippocampal function. Brain Res. 126:1977;567-575.
25. Laviola G., Wood R.D., Kuhn C., Francis R., Spear L.P. Cocaine sensitization in periadolescent and adult rats. J. Pharmacol. Exp. Ther. 275:1995;345-357.
26. Le Moal M., Simon H. Mesocorticolimbic dopaminergic network. Functional and regulatory roles Physiol. Rev. 71:1991;155-234.
27. Lin M.Y., Walters D.E. Dopamine D2 autoreceptors in rats are behaviorally functional at 21 but not 10 days of age. Psychopharmacology (Berlin). 114:1994;262-268.
28. Losada M.E., Carbone S., Szwarcfarb B., Moguilevsky J.A. Amino acid levels in the hypothalamus and response to N-methyl-D-aspartate and/or dizocilpine administration during sexual maturation in female rats. Neuroendocrinology. 57:1993;960-964.
29. Mogenson G.J., Brudzynski S.M., Wu M., Yang C.R., Yim C.C.Y. From motivation to action. A review of dopaminergic regulation of limbic-nucleus accumbens-ventral pallidum-pedunculopontine nucleus circuitries Involved in limbic-motor integration Barnes C.D., Kalivas P.W. Limbic motor circuits and neuropsychiatry. 1993;193-236 CRC Press, Boca Raton, FL.
30. Russell A.T. The clinical presentation of childhood-onset schizophrenia. Schizophr. Bull. 20:1994;631-646.
31. Salamone J.D. The behavioral neurochemistry of motivation. Methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine J. Neurosci. Methods. 64:1996;137-149.
32. Salamone J.D. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav. Brain Res. 61:1994;117-133.
33. Shalaby I.A., Spear L.P. Psychopharmacological effects of low and high doses of apomorphine during ontogeny. Eur. J. Pharmacol. 67:1980;451-459.
34. Smith G.P., Schneider L.H. Relationships between mesolimbic dopamine function and eating behavior. Ann. NY Acad. Sci. 537:1988;254-261.
35. Smith J.K., Neill J.C., Costal B. Bidirectional effects of dopamine D2 receptor antagonists on responding for a conditioned reinforcer. Pharmacol. Biochem. Behav. 57:1997;843-849.
36. Spear L.P., Brake S.C. Periadolescence. Age-dependent behavior and psychopharmacological responsivity in rats Dev. Psychobiol. 16:1983;83-109.
37. Spear L.P., Brick J. Cocaine-induced behavior in the developing rat. Behav. Neural Biol. 26:1979;401-415.
38. Spear L.P., Shalaby I.A., Brick J. Chronic administration of haloperidol during development. Behavioral and psychopharmacological effects Psychopharmacology (Berlin). 70:1980;47-58.
39. Stanwood G.D., McElligot S., Lu L., McGonigle P. Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat. Neurosci. Lett. 223:1997;13-16.
40. Subramaniam S., McGonigle P. Regional profile of developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines. J. Neurochem. 62:1994;1408-1415.
41. Tosyali M.C., Greenhill L.L. Child and adolescent psychopharmacology. Important developmental issues. Pediatr. Clin. North Am. 45:1998;1021-1235.
42. Van Hartesveldt C. Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats. Pharmacol. Biochem. Behav. 58:1997;955-960.
43. Van Hartesveldt C., Cottrell G.A., Potter T., Meyer M.E. Effects of intracerebral quinpirole on locomotion in rats. Eur. J. Pharmacol. 214:1992;27-32.
44. Van Hartesveldt C., Meyer M.E., Potter T.J. Ontogeny of biphasic locomotor effects of quinpirole. Pharmacol. Biochem. Behav. 48:1994;781-786.
45. Walker E.F. Developmentally moderated expressions of the neuropathology underlying schizophrenia. Schizophr. Bull. 20:1994;453-480.
46. Weickert C.S., Weinberger D.R. A candidate molecule approach to defining developmental pathology in schizophrenia. Schizophr. Bull. 24:1998;303-316.
47. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 44:1987;660-669.
48. White F.J., Hu X.T., Zhang X.F. Neuroadaptations in nucleus accumbens neurons resulting from repeated cocaine administration. Adv. Pharmacol. 42:1998;1006-1009.
49. Wise R.A. Drug-activation of brain reward pathways. Drug Alcohol. Depend. 51:1998;13-22.